|
ACTL6A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.499300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.284800E-03 |
| Normal-vs-Stage2 |
8.876700E-03 |
| Normal-vs-Stage3 |
3.753100E-04 |
| Normal-vs-Stage4 |
8.703600E-02 |
| Stage1-vs-Stage2 |
8.335600E-01 |
| Stage1-vs-Stage3 |
1.559350E-01 |
| Stage1-vs-Stage4 |
2.905800E-01 |
| Stage2-vs-Stage3 |
4.584800E-01 |
| Stage2-vs-Stage4 |
3.541000E-01 |
| Stage3-vs-Stage4 |
5.756100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.937270E-03 |
| Normal-vs-AfricanAmerican |
1.400670E-03 |
| Normal-vs-Asian |
6.033600E-01 |
| Caucasian-vs-AfricanAmerican |
2.998000E-01 |
| Caucasian-vs-Asian |
4.487600E-01 |
| AfricanAmerican-vs-Asian |
2.780800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.663420E-03 |
| Normal-vs-Female |
2.583400E-03 |
| Male-vs-Female |
8.268400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.308800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.964400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.302810E-03 |
| Normal-vs-Age(81-100Yrs) |
1.569890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.794200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.784560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.469190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.681000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.432600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.071600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.406600E-01 |
| Normal-vs-Grade 2 |
7.875500E-03 |
| Normal-vs-Grade 3 |
3.822300E-04 |
| Normal-vs-Grade 4 |
1.492140E-02 |
| Grade 1-vs-Grade 2 |
4.810000E-01 |
| Grade 1-vs-Grade 3 |
1.761800E-01 |
| Grade 1-vs-Grade 4 |
2.620000E-01 |
| Grade 2-vs-Grade 3 |
5.254200E-02 |
| Grade 2-vs-Grade 4 |
5.438000E-01 |
| Grade 3-vs-Grade 4 |
7.259600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.674050E-02 |
| Normal-vs-ccB subtype |
1.208430E-04 |
| ccA subtype-vs-ccB subtype |
1.520410E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.724400E-03 |
| Normal-vs-N1 |
3.197800E-01 |
| N0-vs-N1 |
5.448400E-01 |
|
|
